Skip to main content
. 2021 Oct 26;41(11):1195–1227. doi: 10.1002/cac2.12218
Stratification 1 Stratification 2 Grade I recommendations Grade II recommendations Grade III recommendations
Suitable for surgery Local recurrence of nasopharynx Surgery [174, 175, 176, 177, 178, 179, 180, 181, 182, 183] (evidence 1A)

Re‐radiotherapy [174, 175, 176, 177, 178] (evidence 2A)

Chemotherapy/ immunotherapy/ targeted therapy (evidence 2A)

Neck recurrence Surgery [174, 175, 184] (evidence 2A) Radiotherapy [174, 175, 178] (evidence 2A)
Unsuitable for surgery Suitable for radiotherapy Radiotherapy with or without chemotherapy [4, 177, 178, 185] (evidence 2A) Chemotherapy/ immunotherapy/ targeted therapy (evidence 2A)
Unsuitable for radiotherapy Chemotherapy/ immunotherapy/ targeted therapy (evidence 2A)

*This recommendation is based on published papers only.

Refers to chemotherapy/immunotherapy/targeted therapy for metastatic NPC.

Definition of patients unsuitable for surgery: The patient's physical condition does not allow it, the surgery is refused for various reasons, or the tumor burden is too large to be removed.

Definition of patients unsuitable for radiotherapy: They are not expected to benefit from radiotherapy; taking into account factors such as age, Karnofsky performance status (KPS), gross tumor volume (GTV), recurrence T stage; they have regional lymph node metastasis; and they have grade ≥3 adverse events in the previous radiotherapy.